LVIS stent-assisted coiling shows strong aneurysm occlusion in Chinese study
A single-center retrospective study in China found that LVIS stent-assisted coiling achieved high initial occlusion rates in wide-necked intracranial aneurysms and reduced blood-flow measures that remained improved at 6 months. The results point to possible hemodynamic benefits, but also highlight thrombosis risk and the need for larger prospective studies.
Why it matters: - Wide-necked intracranial aneurysms are difficult to treat because coils can shift into the parent artery during embolization. - The study suggests LVIS stent-assisted coiling may do more than hold coils in place. It may also reduce aneurysm inflow and wall shear stress. - Durable flow changes could matter because lower aneurysm flow is linked to thrombosis and healing. - The findings also show real procedural risk, including thrombosis, incomplete stent apposition, and one procedure-related death.
What happened: - A research team led by Professor Xiang Xu at Tangshan Gongren Hospital in China reviewed 61 patients with wide-necked intracranial aneurysms treated with LVIS stent-assisted coiling between January and December 2023. - The group included 35 ruptured aneurysms and 26 unruptured aneurysms. - The study was published in Volume 12 of the Chinese Neurosurgical Journal on June 29, 2026. - The paper is titled “Safety and hemodynamic efficacy of the LVIS stent in the endovascular treatment of intracranial wide-necked aneurysms: a single-center retrospective study.”
The details: - Initial angiography showed complete occlusion in 28 of 35 ruptured aneurysms, or 80.0%. - Initial angiography showed complete occlusion in 22 of 26 unruptured aneurysms, or 84.6%. - Follow-up angiography was available for 27 patients, or 44.3%, at 6-12 months. - All aneurysms that were completely occluded at baseline stayed occluded at follow-up. - Some aneurysms that were initially classified as Raymond-Roy Occlusion Classification class II improved to complete occlusion. - In ruptured cases, favorable functional outcomes, defined as modified Rankin Scale 0-1, rose from 57.1% at discharge to 77.1% at 3-6 months. - In unruptured cases, 25 of 26 patients, or 96.2%, had modified Rankin Scale 0-1 at discharge. - All surviving patients with unruptured aneurysms maintained favorable outcomes at follow-up. - A subset of 14 patients underwent computational fluid dynamics analysis before treatment, after treatment, and at 6 months. - In that subgroup, treatment reduced aneurysm inflow, the share of the aneurysm exposed to higher flow, and average wall shear stress. - Those changes remained significantly different from baseline at 6 months, with all P < 0.001. - The study describes the LVIS stent as a braided, self-expanding nitinol device with relatively high metal coverage. - The study also notes that the LVIS stent is designed as a scaffold across the aneurysm neck and may alter blood flow inside the aneurysm.
Between the lines: - The results are promising, but the study design limits how far they can be applied. - This was a retrospective, single-center study with clinically mixed patients and incomplete imaging follow-up. - The data support an association between LVIS-assisted coiling and favorable flow changes, but they do not prove causation. - The safety signal is mixed: two ruptured aneurysm patients had intraprocedural thrombosis and recovered without permanent neurological deficits, while one unruptured aneurysm patient died after delayed in-stent thrombosis and secondary cerebral hemorrhage. - Incomplete stent apposition occurred in 6 of 61 patients, or 9.8%, which may help explain thrombotic risk.
What's next: - The authors call for larger prospective comparative studies to test safety, efficacy, and patient selection. - Future work should examine stent deployment quality, thrombotic risk, and outcomes across both ruptured and unruptured aneurysms. - The study also points to a need for closer collaboration among neurointerventional, imaging, and computational researchers.
The bottom line: - LVIS stent-assisted coiling delivered strong early aneurysm occlusion and durable hemodynamic improvement in this study, but thrombosis risk and limited follow-up mean the device still needs stronger prospective evidence.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
China Health Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.